About
Vaccine
Areas of Focus
Categories
Vaccine
Clinical Trials (10)
View allTotal Trials
10
As Lead Sponsor
9
As Collaborator
1
Total Enrollment
1,998
By Phase
PHASE2/PHASE3: 2PHASE1: 4PHASE2: 2PHASE4: 1
By Status
COMPLETED: 7RECRUITING: 1NOT_YET_RECRUITING: 1ENROLLING_BY_INVITATION: 1
Clinical Trials Pipeline10 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
Hover over trial bars to see details
Recent Trials
NCT06592586Lead Sponsor
A Follow-up Trial of GBS-NN/NN2 Vaccine in Healthy Pregnant Women
PHASE2/PHASE3Recruiting
338 participants
Started: Mar 7, 2025 · Completed: Jun 30, 2029
NCT06494475Lead Sponsor
GBS-NN/NN2 (50 µg of Each Fusion Protein [GBS-NN and GBS-NN2] in Combination With 500 µg Aluminum as Alhydrogel®) Given With and Without the Tdap Vaccine in Healthy Non-pregnant Women 18 to 49 Years of Age
PHASE2/PHASE3Not yet recruiting
564 participants
Started: Dec 17, 2024 · Completed: Jun 21, 2025
NCT06280157Lead Sponsor
A Follow up Study of Group B Streptococcus (GBS)-NN/NN2 Vaccine in Healthy Volunteers
N/AEnrolling by invitation
55 participants
Started: Jan 18, 2024 · Completed: Jan 31, 2028
NCT05782179Lead Sponsor
Study to Evaluate the Safety, Tolerability and Immunogenicity of Three Doses of GBS Vaccine in Elderly Participants
PHASE1Completed
90 participants
Started: Mar 1, 2023 · Completed: May 23, 2024
NCT05154578Lead Sponsor
Immunogenicity and Safety of GBS-NN/NN2 in Pregnant Women
PHASE2Completed
269 participants
Started: Feb 17, 2022 · Completed: Oct 18, 2023
Locations (1)
Headquarters
Copenhagen, Denmark
Map
Loading map...